II
106TH CONGRESS
2D SESSION
H. R. 4281
IN THE SENATE OF THE UNITED STATES
OCTOBER 18 (legislative day, SEPTEMBER 22), 2000
Received
AN ACT
To establish, wherever feasible, guidelines, recommendations,
and regulations that promote the regulatory acceptance
of new or revised scientifically valid toxicological tests
that protect human and animal health and the environ-
ment while reducing, refining, or replacing animal tests
and ensuring human safety and product effectiveness.
HR 4281 RDS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘ICCVAM Authoriza-
tion Act of 2000’’.
SEC. 2. DEFINITIONS.
In this Act:
(1) ALTERNATIVE
TEST
METHOD.—The term
‘‘alternative test method’’ means a test method
that—
(A) includes any new or revised test meth-
od; and
(B)(i) reduces the number of animals re-
quired;
(ii) refines procedures to lessen or elimi-
nate pain or distress to animals, or enhances
animal well-being; or
(iii) replaces animals with non-animal sys-
tems or 1 animal species with a phylogenetically
lower animal species, such as replacing a mam-
mal with an invertebrate.
(2) ICCVAM TEST
RECOMMENDATION.—The
term ‘‘ICCVAM test recommendation’’ means a
summary report prepared by the ICCVAM charac-
HR 4281 RDS
terizing the results of a scientific expert peer review
of a test method.
SEC. 3. INTERAGENCY COORDINATING COMMITTEE ON THE
VALIDATION OF ALTERNATIVE METHODS.
(a) IN GENERAL.—With respect to the interagency
coordinating committee that is known as the Interagency
Coordinating Committee on the Validation of Alternative
Methods (referred to in this Act as ‘‘ICCVAM’’) and that
was established by the Director of the National Institute
of Environmental Health Sciences for purposes of section
463A(b) of the Public Health Service Act, the Director
of the Institute shall designate such committee as a per-
manent interagency coordinating committee of the Insti-
tute under the National Toxicology Program Interagency
Center for the Evaluation of Alternative Toxicological
Methods. This Act may not be construed as affecting the
authorities of such Director regarding ICCVAM that were
in effect on the day before the date of the enactment of
this Act, except to the extent inconsistent with this Act.
(b) PURPOSES.—The purposes of the ICCVAM shall
be to—
(1) increase the efficiency and effectiveness of
Federal agency test method review;
HR 4281 RDS
(2) eliminate unnecessary duplicative efforts
and share experiences between Federal regulatory
agencies;
(3) optimize utilization of scientific expertise
outside the Federal Government;
(4) ensure that new and revised test methods
are validated to meet the needs of Federal agencies;
and
(5) reduce, refine, or replace the use of animals
in testing, where feasible.
(c) COMPOSITION.—The ICCVAM shall be composed
of the heads of the following Federal agencies (or their
designees):
(1) Agency for Toxic Substances and Disease
Registry.
(2) Consumer Product Safety Commission.
(3) Department of Agriculture.
(4) Department of Defense.
(5) Department of Energy.
(6) Department of the Interior.
(7) Department of Transportation.
(8) Environmental Protection Agency.
(9) Food and Drug Administration.
(10) National Institute for Occupational Safety
and Health.
HR 4281 RDS
(11) National Institutes of Health.
(12) National Cancer Institute.
(13) 
National 
Institute 
of 
Environmental
Health Sciences.
(14) National Library of Medicine.
(15) Occupational Safety and Health Adminis-
tration.
(16) Any other agency that develops, or em-
ploys tests or test data using animals, or regulates
on the basis of the use of animals in toxicity testing.
(d) SCIENTIFIC ADVISORY COMMITTEE.—
(1) ESTABLISHMENT.—The Director of the Na-
tional Institute of Environmental Health Sciences
shall establish a Scientific Advisory Committee (re-
ferred to in this Act as the ‘‘SAC’’) to advise
ICCVAM and the National Toxicology Program
Interagency Center for the Evaluation of Alternative
Toxicological Methods regarding ICCVAM activities.
The activities of the SAC shall be subject to provi-
sions of the Federal Advisory Committee Act.
(2) MEMBERSHIP.—
(A) IN GENERAL.—The SAC shall be com-
posed of the following voting members:
(i) At least 1 knowledgeable rep-
resentative having a history of expertise,
HR 4281 RDS
development, or evaluation of new or re-
vised or alternative test methods from each
of—
(I) the personal care, pharma-
ceutical, industrial chemicals, or agri-
culture industry;
(II) any other industry that is
regulated by the Federal agencies
specified in subsection (c); and
(III) a national animal protection
organization established under section
501(c)(3) of the Internal Revenue
Code of 1986.
(ii) Representatives (selected by the
Director of the National Institute of Envi-
ronmental Health Sciences) from an aca-
demic institution, a State government
agency, an international regulatory body,
or any corporation developing or marketing
new or revised or alternative test meth-
odologies, including contract laboratories.
(B) NONVOTING EX OFFICIO MEMBERS.—
The membership of the SAC shall, in addition
to voting members under subparagraph (A), in-
clude as nonvoting ex officio members the agen-